Fe-curcumin nanozyme-mediated immunosuppression and anti-inflammation in experimental autoimmune uveitis
Zhengxuan Jiang, Kun Liang, Xiang Gao, Fan Cao, Guangqi An, Siyu Gui, Weiwei Tang, Liping Du, Liming Tao, Xianwen Wang · 2023
Read Fe-curcumin nanozyme-mediated immunosuppression and anti-inflammation in experimental autoimmune uveitis by Zhengxuan Jiang, Kun Liang, Xiang Gao, Fan Cao, Guangqi An, Siyu Gui, Weiwei Tang, Liping Du, Liming Tao, Xianwen Wang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10717250.txt.
Description
Zhengxuan Jiang and co-authors build an iron-curcumin nanozyme to treat experimental autoimmune uveitis, an inflammatory eye disease. Their 2023 paper notes that the disease is driven by autoinflammation, autoimmunity, and excess reactive oxygen species.
Hormone therapy is the usual route but brings many adverse effects. In their nanozyme, natural antioxidants coordinate with iron ions to form nanoparticles with good solubility. Lab tests checked the particles and their power to scavenge free radicals. In a rat model of the disease, the nanozyme reduced inflammation and autoimmune activity. Tests on blood cells also showed it could hold back cell proliferation, a sign of immune suppression.
Catalog record
| CREATOR | Zhengxuan Jiang, Kun Liang, Xiang Gao, Fan Cao, Guangqi An, Siyu Gui, Weiwei Tang, Liping Du, Liming Tao, Xianwen Wang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |